Travel Grant 2024, Korea, BIOKOREA, 8-10 maj 2024

250K kr SEK

Funder	Vinnova
Recipient Organization	Svenska Vacinfabriken Produktion Ab
Country	Sweden
Start Date	May 05, 2024
End Date	May 11, 2024
Duration	6 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	Swedish Research Council
Grant ID	`2024-00385_Vinnova`

Grant Description

Purpose and goal: BioKorea 2024 Objectives: 1. Identify Korean VCs to invest in SVF Vaccines: Not fulfilled

2. Identify Korean corporate partner for SVF-001: Fulfilled - one Korean company has expressed an interest in the partnering the SVF-001 project

3. Continue discussions with Korean CDMOs. Fulfilled. One site visit to a Korean CDMO was made and a face-to-face meeting was held with senior staff from a second Korean CDMO. Expected results and effects: Objective 2. Partnership discussions are expected to start within several weeks with the potential Korean collaborator.

Objective 3: Contract discussions will now be initiated with the preferred Korean CDMO following the successful on-site meetings at their manufacturing facility Approach and implementation:

Objective 2: Implementation will be initiated through conceptual discussions regarding the collaboration, followed by term sheet exchanges and concluded with a final legal agreement. Objective 3: Further technical meetings will be held in parallel with contract discussions